Ocean Biomedical Total Liab Over Time
OCEAW Stock | 0.04 0 9.32% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ocean Biomedical Performance and Ocean Biomedical Correlation. Ocean |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Liab Analysis
Compare Ocean Biomedical and related stocks such as Harmony Gold Mining, Treasury Wine Estates, and Zijin Mining Group Total Liab Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FIZZ | 135.8 M | 101.4 M | 138.3 M | 116.6 M | 100 M | 99.3 M | 112.3 M | 127.4 M | 120.6 M | 196.3 M | 201.2 M | 228.4 M | 201.9 M | 210.6 M | 95.7 M |
PEP | 4 B | 52 B | 52.2 B | 53.1 B | 53 B | 57.6 B | 62.9 B | 68.8 B | 63 B | 63.7 B | 79.4 B | 76.2 B | 74.9 B | 81.9 B | 86 B |
Ocean Biomedical and related stocks such as Harmony Gold Mining, Treasury Wine Estates, and Zijin Mining Group Total Liab description
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.My Equities
My Current Equities and Potential Positions
Ocean Biomedical | OCEAW |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Exchange | NASDAQ Exchange |
null 0.0399
Additional Tools for Ocean Stock Analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.